Protein kinase C and epidermal growth factor stimulation of Raf1 potentiates adenylyl cyclase type 6 activation in intact cells

Molecular Pharmacology

Volumn 67, Issue 1, 2005, Pages 250-259

  Beazely, Michael A ^a   Alan, Jamie K ^a   Watts, Val J ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FORSKOLIN; GW 5074; ISOPRENALINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE RAF 1 INHIBITOR; RAF PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; DRUG INHIBITION; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; WILD TYPE;

ADENYLATE CYCLASE; ANIMALS; BASE SEQUENCE; CELL LINE; CHO CELLS; CRICETINAE; DNA PRIMERS; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; FORSKOLIN; HUMANS; ISOPROTERENOL; KIDNEY; KINETICS; MUTAGENESIS, SITE-DIRECTED; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-RAF; RECOMBINANT PROTEINS; TETRADECANOYLPHORBOL ACETATE; TRANSFECTION;

EID: 11244325007     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.001370     Document Type: Article

References (46)

1. Avidor-Reiss T, Nevo I, Levy R, Pfeuffer T, and Vogel Z (1996) Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gβγ. J Biol Chem 271:21309-21315.
2. Bol GF, Hulster A, and Pfeuffer T (1997) Adenylyl cyclase type II is stimulated by PKC via C-terminal phosphorylation. Biochim Biophys Acta 1358:307-313.
3. Brtva TR, Drugan JK, Ghosh S, Terrell RS, Campbell-Burk S, Bell RM, and Der CJ (1995) Two distinct Raf domains mediate interaction with Ras. J Biol Chem 270:9809-9812.
4. 2+ increase in the inhibition of intracellular cAMP content. Cell Signal 11:651-663.
5. Chen Y, Harry A, Li J, Smit MJ, Bai X, Magnusson R, Pieroni JP, Weng G, and Iyengar R (1997) Adenylyl cyclase 6 is selectively regulated by protein kinase A phosphorylation in a region involved in Galphas stimulation. Proc Natl Acad Sci USA 94:14100-14104.
6. Chen Z, Nield HS, Sun H, Barbier A, Patel TB, Nair BG, Yu Y, Parikh B, Milligan G, and Rashed HM (1995) Expression of type V adenylyl cyclase is required for epidermal growth, factor-mediated stimulation of cAMP accumulation. J Biol Chem 270:27525-27530.
7. Chern Y (2000) Regulation of adenylyl cyclase in the central nervous system. Cell Signal 12:195-204.
8. Defer N, Best-Belpomme M, and Hanoune J (2000) Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase. Am J Physiol 279:F400-F416.
9. Ding Q, Gros R, Gray ID, Taussig R, Ferguson SSG, and Feldman RD (2004) Raf kinase activation of adenylyl cyclases: isoform-selective regulation. Mol Pharmacol 66:321-928.
10. Jacobowitz O, Chen J, Premont RT, and Iyengar R (1993) Stimulation of specific types of Gs-stimulated adenylyl cyclases by phorbol ester treatment. J Biol Chem 268:3829-3832.
11. Jacobowitz O and Iyengar R (1994) Phorbol ester-induced stimulation and phosphorylation of adenylyl cyclase 2. Proc Natl Acad Sci USA 91:10630-10634.
12. Johnston CA, Beazely MA, Bilodeau ML, Andrisani O, and Watts VJ (2004) Differentiation-induced alterations in cyclic AMP signaling in the Cath.a differentiated (CAD) neuronal cell line. J Neurochem 88:1497-1508.
13. Johnston CA, Beazely MA, Vancura AF, Wang JK, and Watts VJ (2002) Heterologous sensitization of adenylate cyclase is protein kinase A-dependent in Cath.a differentiated (CAD)-D2L cells. J Neurochem 82:1087-1096.
14. Kawabe J, Ebina T, Toya Y, Oka N, Schwencke C, Duzic E, and Ishikawa Y (1996) Regulation of type V adenylyl cyclase by PMA-sensitive and -insensitive protein kinase C isoenzymes in intact cells. FEBS Lett 384:273-276.
15. Kawabe J, Iwami G, Ebina T, Ohno S, Katada T, Ueda Y, Homcy CJ, and Ishikawa Y (1994) Differential activation of adenylyl cyclase by protein kinase C isoenzymes. J Biol Chem 269:16554-16558.
16. Lai HL, Lin TH, Kao YY, Lin WJ, Hwang MJ, and Chern Y (1999) The N terminus domain of type VI adenylyl cyclase mediates its inhibition by protein kinase C. Mol Pharmacol 56:644-650.
17. Lai HL, Yang TH, Messing RO, Ching YH, Lin SC, and Chern YJ (1997) Protein kinase C inhibits adenylyl cyclase type VI activity during desensitization of the A2a-adenosine receptor-mediated cAMP response. J Biol Chem 272:4970-4977.
18. Leevers SJ, Paterson HF, and Marshall CJ (1994) Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature (Lond) 369:411-414.
19. Lin TH, Lai HL, Kao YY, Sun CN, Hwang MJ, and Chern Y (2002) Protein kinase C inhibits type VI adenylyl cyclase by phosphorylating the regulatory N domain and two catalytic C1 and C2 domains. J Biol Chem 277:15721-15728.
20. Luttrell LM (2002) Activation and targeting of mitogen-activated protein kinases by G-protein-coupled receptors. Can J Physiol Pharmacol 80:375-382.
21. Nair BG, Parikh B, Milligan G, and Patel TB (1990) Gs alpha mediates epidermal growth factor-elicited stimulation of rat cardiac adenylate cyclase. J Biol Chem 265:21317-21322.
22. Nair BG, Patel TB, Yu Y, Parikh B, Milligan G, and Rashed HM (1993) Regulation of cardiac adenylyl cyclase by epidermal growth factor (EGF). Role of EGF receptor protein tyrosine kinase activity. Biochem Pharmacol 46:1239-1245.
23. Nair BG, Rashed HM, and Patel TB (1989) Epidermal growth factor stimulates rat cardiac adenylate cyclase through a GTP-binding regulatory protein. Biochem J 264:563-571.
24. Poppleton H, Sun H, Fulgham D, Bertics P, and Patel TB (1996) Activation of Gsα by the epidermal growth factor receptor involves phosphorylation. J Biol Chem 271:6947-6951.
25. Prenzel N, Fischer OM, Streit S, Hart S, and Ullrich A (2001) The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocr Relat Cancer 8:11-31.
26. 1 cannabinoid receptor. Mol Pharmacol 57:746-752.
27. 2+-sensitive, phospholipid-dependent protein kinase activity in phorbol ester-treated 3T3 cells. Biochem Biophys Res Commun 120:1053-1059.
28. Rubenzik M, Varga E, Stropova D, Roeske WR, and Yamamura HI (2001) Expression of α-transducin in Chinese hamster ovary cells stably transfected with the human δ-opioid receptor attenuates chronic opioid agonist-induced adenylyl cyclase superactivation. Mol Pharmacol 60:1076-1082.
29. Schaap D, van der Wal J, Howe LR, Marshall CJ, and van Blitterswijk WJ (1993) A dominant-negative mutant of raf blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21ras. J Biol Chem 268:20232-20236.
30. Schwindinger WF and Robishaw JD (2001) Heterotrimeric G-protein betagamma-dimers in growth and differentiation. Oncogene 20:1653-1660.
31. Singh TJ, Hochman J, Verna R, Chapman M, Abraham I, Pastan IH, and Gottesman MM (1985) Characterization of a cyclic AMP-resistant Chinese hamster ovary cell mutant containing both wild-type and mutant species of type I regulatory subunit of cyclic AMP-dependent protein kinase. J Biol Chem 260:13927-31393.
32. Stabel S, Rodriguez-Pena A, Young S, Rozengurt E, and Parker PJ (1987) Quantitation of protein kinase C by immunoblot-expression in different cell lines and response to phorbol esters. J Cell Physiol 130:111-117.
33. Stokoe D, Macdonald SG, Cadwallader K, Symons M, and Hancock JF (1994) Activation of Raf as a result of recruitment to the plasma membrane. Science (Wash DC) 264:1463-1467.
34. Tan CM, Kelvin DJ, Litchfield DW, Ferguson SS, and Feldman RD (2001) Tyrosine kinase-mediated serine phosphorylation of adenylyl cyclase. Biochemistry 40:1702-1709.
35. Thomas JM and Hoffman BB (1996) Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: role of βγ subunits in transducing enhanced activity of the type VI isoform. Mol Pharmacol 49:907-914.
36. Ueda Y, Hirai S, Osada S, Suzuki A, Mizuno K, and Ohno S (1996) Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J Biol Chem 271:23512-23519.
37. Varga EV, Rubenzik M, Grife V, Sugiyama M, Stropova D, Roeske WR, and Yamamura HI (2002) Involvement of Raf-1 in chronic delta-opioid receptor agonist-mediated adenylyl cyclase superactivation. Eur J Pharmacol 451:101-102.
38. Varga EV, Rubenzik MK, Stropova D, Sugiyama M, Grife V, Hruby VJ, Rice KC, Roeske WR, and Yamamura HI (2003) Converging protein kinase pathways mediate adenylyl cyclase superactivation upon chronic δ-opioid agonist treatment. J Pharmacol Exp Ther 306:109-115.
39. Varga EV, Stropova D, Rubenzik M, Waite S, Roeske WR, and Yamamura HI (1999) Phosphorylation of adenylyl cyclase VI upon chronic delta-opioid receptor stimulation. Eur J Pharmacol 364:R1-R3.
40. Varga EV, Stropova D, Rubenzik M, Wang M, Landsman RS, Roeske WR, and Yamamura HI (1998) Identification of adenylyl cyclase isoenzymes in CHO and B82 cells. Eur J Pharmacol 348:R1-R2.
41. Ventura AL and Sibley DR (2000) Altered regulation of the D(1) dopamine receptor in mutant Chinese hamster ovary cells deficient in cyclic AMP-dependent protein kinase activity. J Pharmacol Exp Ther 293:426-434.
42. Watts VJ (2002) Molecular mechanisms for heterologous sensitization of adenylate cyclase. J Pharmacol Exp Ther 302:1-7.
43. Watts VJ and Neve KA (1996) Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors. Mol Pharmacol 50:966-976.
44. Wu GC, Lai HL, Lin YW, Chu YT, and Chern Y (2001) N-glycosylation and residues Asn805 and Asn890 are involved in the functional properties of type VI adenylyl cyclase. J Biol Chem 276:35450-35457.
45. Yoshimura M and Cooper DM (1993) Type-specific stimulation of adenylyl cyclase by protein kinase C. J Biol Chem 268:4604-4607.
46. Yu Y, Nair BG, Patel TB, Parikh B, Milligan G, and Hashed HM (1992) Epidermal growth factor stimulates cAMP accumulation in cultured rat cardiac myocytes. J Cell Physiol 150:559-567.